drugset / Trial / NCT00650897
Efficacy Study of Escitalopram for Depression in Patients With Diabetes
NaSingle-groupOpen-labelTreatment
Summary
Patients with diabetes and major depression treated with Escitalopram might experience significant improvement in depression and anxiety scores; functional ability; diabetes-related self-care; and pain symptoms
Timeline
- Start
- 2008-04
- Primary completion
- 2009-06
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 10 mg | — |
| Subject | Escitalopram | Small molecule | 20 mg | — |